Diabetic Neuropathy Clinical Trials 2022
Browse 10 Diabetic Neuropathy Medical Studies Across 14 Cities
19 Diabetic Neuropathy Clinics
Reviewed by Michael Gill, B. Sc.
10 Diabetic Neuropathy Clinical Trials Near Me
Top Hospitals for Diabetic Neuropathy Clinical Trials
University Hospitals Cleveland Medical Center/ Dahms Clinical Research Unit
Cleveland
2Active Trials
2All Time Trials for Diabetic Neuropathy
2019First Diabetic Neuropathy Trial
CT-100 Study Center
New York
1Active Trials
1All Time Trials for Diabetic Neuropathy
2022First Diabetic Neuropathy Trial
Click Therapeutics
New York
1Active Trials
1All Time Trials for Diabetic Neuropathy
2022First Diabetic Neuropathy Trial
University of Illinois Health/ University of Illinois at Chicago
Hinsdale
1Active Trials
1All Time Trials for Diabetic Neuropathy
2022First Diabetic Neuropathy Trial
Top Cities for Diabetic Neuropathy Clinical Trials
Hinsdale
2Active Trials
University of Illinois Health/ University of Illinois at ChicagoTop Active Site
Cleveland
2Active Trials
University Hospitals Cleveland Medical Center/ Dahms Clinical Research UnitTop Active Site
Diabetic Neuropathy Clinical Trials by Phase of Trial
Phase < 1 Diabetic Neuropathy Clinical Trials
1Active Diabetic Neuropathy Clinical Trials
1Number of Unique Treatments
0Number of Active Locations
Diabetic Neuropathy Clinical Trials by Age Group
18+ Diabetic Neuropathy Clinical Trials
10Active Diabetic Neuropathy Clinical Trials
Most Recent Diabetic Neuropathy Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Top Treatments for Diabetic Neuropathy Clinical Trials
Recently Completed Studies with FDA Approved Treatments for Diabetic Neuropathy Treatment Name
Active Diabetic Neuropathy Clinical Trials
All Time Trials for Diabetic Neuropathy
First Recorded Diabetic Neuropathy Trial
DiNaMo Study App
1
1
2022
Active tDCS + Active TUS
1
1
2022
Erchonia® EVRL™
1
1
2022
Fish Oil Concentrate, 1000 Mg Oral Capsule
1
1
2022
Fish-oil derived n-3 polyunsaturated fatty acids
1
1
2021
Treatment
Year
Sponsor
LY3526318
2022
Eli Lilly and Company
Active: WST-057 4mL (146 mg pirenzepine free base monohydrate) topical solution
2020
WinSanTor, Inc
ETX-018810
2020
Eliem Therapeutics (UK) Ltd.
LY3016859
2020
Eli Lilly and Company
WST-057 (4% pirenzepine) Lose Dose 2mL
2019
WinSanTor, Inc
About The Author
Michael Gill - B. Sc.
First Published: October 26th, 2021
Last Reviewed: November 6th, 2022
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Relevant Clinical Trials
Top Oncology Trials
Popular Clinical Trials
References1 Cella D, Lai JS, Nowinski CJ, Victorson D, Peterman A, Miller D, Bethoux F, Heinemann A, Rubin S, Cavazos JE, Reder AT, Sufit R, Simuni T, Holmes GL, Siderowf A, Wojna V, Bode R, McKinney N, Podrabsky T, Wortman K, Choi S, Gershon R, Rothrock N, Moy C. Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology. 2012 Jun 5;78(23):1860-7. doi: 10.1212/WNL.0b013e318258f744. Epub 2012 May 9. https://pubmed.ncbi.nlm.nih.gov/225736262 Weiss JN, Levy S. Neurologic Stem Cell Treatment Study (NEST) using bone marrow derived stem cells for the treatment of neurological disorders and injuries: study protocol for a nonrandomized efficacy trial. Clin Trials Degener Dis. 2016 [cited 2019 Jun 18];1:176-80. 3 Chapman CD, Frey WH 2nd, Craft S, Danielyan L, Hallschmid M, Schiöth HB, Benedict C. Intranasal treatment of central nervous system dysfunction in humans. Pharm Res. 2013 Oct;30(10):2475-84. doi: 10.1007/s11095-012-0915-1. Epub 2012 Nov 8. Review. https://pubmed.ncbi.nlm.nih.gov/231358224 Cella D, Nowinski C, Peterman A, Victorson D, Miller D, Lai JS, Moy C. The neurology quality-of-life measurement initiative. Arch Phys Med Rehabil. 2011 Oct;92(10 Suppl):S28-36. doi: 10.1016/j.apmr.2011.01.025. https://pubmed.ncbi.nlm.nih.gov/219589205 Chiviacowsky S, Wulf G, Wally R. An external focus of attention enhances balance learning in older adults. Gait Posture. 2010 Oct;32(4):572-5. doi: 10.1016/j.gaitpost.2010.08.004. Epub 2010 Sep 17. https://pubmed.ncbi.nlm.nih.gov/208503256 Lescaudron L, Naveilhan P, Neveu I. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases. Curr Med Chem. 2012;19(35):6018-35. Review. https://pubmed.ncbi.nlm.nih.gov/229635677 Teixeira FG, Carvalho MM, Sousa N, Salgado AJ. Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? Cell Mol Life Sci. 2013 Oct;70(20):3871-82. doi: 10.1007/s00018-013-1290-8. Epub 2013 Mar 1. Review. https://pubmed.ncbi.nlm.nih.gov/234562568 Jiang Y, Zhu J, Xu G, Liu X. Intranasal delivery of stem cells to the brain. Expert Opin Drug Deliv. 2011 May;8(5):623-32. doi: 10.1517/17425247.2011.566267. Epub 2011 Mar 19. Review. https://pubmed.ncbi.nlm.nih.gov/214177829 Bhasin A, Srivastava M, Bhatia R, Mohanty S, Kumaran S, Bose S. Autologous intravenous mononuclear stem cell therapy in chronic ischemic stroke. J Stem Cells Regen Med. 2012 Nov 26;8(3):181-9. eCollection 2012. https://pubmed.ncbi.nlm.nih.gov/2469319610 Laroni A, de Rosbo NK, Uccelli A. Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond neuroprotection. Immunol Lett. 2015 Dec;168(2):183-90. doi: 10.1016/j.imlet.2015.08.007. Epub 2015 Aug 18. Review. https://pubmed.ncbi.nlm.nih.gov/26296458
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments